Skip to content
PolyBio Industries Ltd. Farm-to-Pharma · Industrial Biotechnology

Impact

Designed for impact.
Measured before claimed.

Nine areas the platform is built to change — and a commitment about what we will and will not publish.

01

Farmer value

A year-round industrial buyer changes what surplus is worth. The objective is a more predictable market and less exposure to seasonal price collapse for the farms that supply the plant.

02

Agricultural value addition

Raw crop leaves the farm; a refined ingredient leaves the plant. The margin between the two is created inside Bangladesh instead of abroad.

03

Import substitution

Domestic supply of starch-based ingredients that pharmaceutical and food manufacturers currently import, reducing foreign-currency outflow.

04

Rural industrialisation

Industrial capacity placed in the agricultural belt rather than only around the capital, with the employment that comes with it.

05

Employment

Direct plant employment plus indirect work in sourcing, logistics, maintenance and services around the facility.

06

Pharmaceutical supply chain localisation

A domestic source for an input the national pharmaceutical industry currently depends on imports to secure.

07

Circular economy

Pulp, protein, organic residue and process water are designed as recovery streams from the outset, not as waste to be managed later.

08

Resource efficiency

Water recirculation and energy recovery reduce the resource cost of each tonne processed.

09

Regional industrial development

A processing anchor that makes further agro-industrial investment in Northern Bangladesh more viable.

Measurement

Our reporting commitment

What we will publish

Farmer volumes and payments, employment created, tonnes processed, water and energy per tonne, and by-product recovery rates.

When we will publish it

Once the plant operates and the figures are measured. Not before.

What we will not publish

Projected impact numbers presented as achievement. Estimates will always be labelled as estimates.

Development stage. This page describes the impact the platform is designed to create. PolyBio Industries Ltd. is a development-stage company and has no operating results to report. No impact statistics are published on this website because none have been measured.